Skip to main content
JEIL PHARMACEUTICAL CO.,LTD logo

JEIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 271980 ISIN · KR7271980005 KO Manufacturing
Filings indexed 135 across all filing types
Latest filing 2024-09-05 Regulatory Filings
Country KR South Korea
Listing KO 271980

About JEIL PHARMACEUTICAL CO.,LTD

https://www.jeilpharm.co.kr/english/

JEIL PHARMACEUTICAL CO.,LTD. is a company engaged in the development, manufacturing, and distribution of pharmaceutical products. Its portfolio includes both finished drug products and Active Pharmaceutical Ingredients (APIs). The company produces a diverse range of dosage forms, such as solid medicines (tablets and capsules), patches, and injections, with a strategic focus on becoming a leading manufacturer of injection-based medicines. Committed to developing high-value products, the company operates KGMP-certified manufacturing facilities. Research and development activities are central to its operations, driven by its dedicated R&D center.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Jeil Pharmaceutical regarding the signing of a single sales and supply contract (distribution and marketing agreement) with Dong-A ST. Since this is a specific regulatory disclosure of a material business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2024-09-05 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Jeil Pharmaceutical Co., Ltd., covering the period from January 1, 2024, to June 30, 2024. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Jeil Pharmaceutical Co., Ltd., covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, business operations, management discussion, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과) for Jeil Pharmaceutical. It details the approval of financial statements, dividend declarations, and board-related resolutions. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and details about the external auditor. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body, rather than the full annual report (10-K) itself. According to the 'Menu vs Meal' rule, this is a report publication announcement/regulatory filing. FY 2023
2024-03-12 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Jeil Pharmaceutical Co., Ltd. for the fiscal year ending December 31, 2023. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This constitutes a full annual financial report, which falls under the 'Annual Report' (10-K) category in the provided schema. FY 2023
2024-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.